Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Non-Current Deffered Revenue (2016 - 2025)

Jaguar Health (JAGX) has disclosed Non-Current Deffered Revenue for 5 consecutive years, with $425000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Non-Current Deffered Revenue fell 28.57% to $425000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $425000.0, a 28.57% decrease, with the full-year FY2024 number at $553000.0, changed N/A from a year prior.
  • Non-Current Deffered Revenue was $425000.0 for Q3 2025 at Jaguar Health, down from $468000.0 in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $680000.0 in Q1 2024 to a low of $425000.0 in Q3 2025.